Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Hypertension medication use and adherence among adults with developmental disability.

Vacek JL, Hunt SL, Shireman T.

Disabil Health J. 2013 Oct;6(4):297-302. doi: 10.1016/j.dhjo.2013.02.003. Epub 2013 Apr 2.

PMID:
24060252
2.

Antihypertensive persistence and drug class.

Marentette MA, Gerth WC, Billings DK, Zarnke KB.

Can J Cardiol. 2002 Jun;18(6):649-56.

PMID:
12107422
3.

Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data.

Lachaine J, Petrella RJ, Merikle E, Ali F.

Can J Cardiol. 2008 Apr;24(4):269-73.

4.

Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population.

Baggarly SA, Kemp RJ, Wang X, Magoun AD.

Res Social Adm Pharm. 2014 Nov-Dec;10(6):e99-112. doi: 10.1016/j.sapharm.2014.02.002. Epub 2014 Feb 15.

PMID:
24731547
5.

Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.

Patel BV, Remigio-Baker RA, Mehta D, Thiebaud P, Frech-Tamas F, Preblick R.

J Clin Hypertens (Greenwich). 2007 Sep;9(9):692-700.

6.

Geographic variation in cardioprotective antihypertensive medication usage in dialysis patients.

Wetmore JB, Mahnken JD, Mukhopadhyay P, Hou Q, Ellerbeck EF, Rigler SK, Spertus JA, Shireman TI.

Am J Kidney Dis. 2011 Jul;58(1):73-83. doi: 10.1053/j.ajkd.2011.02.387. Epub 2011 May 31.

8.

Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 2001-2005.

Weiss R, Buckley K, Clifford T.

J Clin Hypertens (Greenwich). 2006 Oct;8(10):706-12.

9.

Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice.

Corrao G, Rea F, Ghirardi A, Soranna D, Merlino L, Mancia G.

Hypertension. 2015 Oct;66(4):742-9. doi: 10.1161/HYPERTENSIONAHA.115.05463. Epub 2015 Jul 27.

10.
11.

Treating hypertension. Are the right drugs given to the right patients?

Beaulieu MD, Dufresne L, LeBlanc D.

Can Fam Physician. 1998 Feb;44:294-8, 301-2.

12.

Associations between birth weight and antihypertensive medication in black and white medicaid recipients.

Lackland DT, Egan BM, Syddall HE, Barker DJ.

Hypertension. 2002 Jan;39(1):179-83.

13.

Antihypertensive drug therapy in Saskatchewan: patterns of use and determinants in hypertension.

Bourgault C, Rainville B, Suissa S.

Arch Intern Med. 2001 Aug 13-27;161(15):1873-9.

PMID:
11493129
14.

Patterns of treatment modifications among newly treated hypertensive patients: does choice of modification strategy affect likelihood of treatment discontinuation?

Sonawane KB, Qian J, Garza KB, Wright BM, Zeng P, Ganduglia-Cazaban CM, Hansen RA.

J Hypertens. 2016 Mar;34(3):548-57; discussion 557. doi: 10.1097/HJH.0000000000000806.

PMID:
26820480
15.

Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.

Ah YM, Lee JY, Choi YJ, Kim B, Choi KH, Kong J, Oh JM, Shin WG, Lee HY.

J Korean Med Sci. 2015 Dec;30(12):1800-6. doi: 10.3346/jkms.2015.30.12.1800. Epub 2015 Nov 30.

16.

Prescribing pattern of antihypertensive drugs in the community.

Rotmensch HH, Mendelevitch L, Silverberg DS, Liron M.

J Hum Hypertens. 1996 Sep;10 Suppl 3:S169-72.

PMID:
8872853
18.

Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.

Tu K, Anderson LN, Butt DA, Quan H, Hemmelgarn BR, Campbell NR, McAlister FA; Hypertension Outcome and Surveillance Team.

Can J Cardiol. 2014 Jun;30(6):647-52. doi: 10.1016/j.cjca.2014.03.017. Epub 2014 Mar 18.

PMID:
24882536

Supplemental Content

Support Center